相关实验视频
Updated: Jul 15, 2025

11:58
A Protocol for Roux-en-Y Gastric Bypass in Rats using Linear Staplers
Published on: August 21, 2021
5.5K
糖尿病缓解后LRYGBP与和没有 fundus切除:一个随机临床试验
Dimitrios Kehagias1, Charalampos Lampropoulos2, Neoklis Georgopoulos3
1University of Patras, 26504, Rio, Greece. dimikech@gmail.com.
Obesity surgery
|October 2, 2023
概括
在胃旁路手术中添加 fundus 切除并没有改善 II 型糖尿病患者的血糖控制. 虽然这两种手术都导致了显著的体重减轻和增加有益的肠道激素,但修改后的手术并没有提供更好的葡萄糖调节.
科学领域:
- 代谢手术是一种代谢手术.
- 内分泌学 在内分泌学.
- 减肥手术 减肥手术是什么
背景情况:
- 代谢手术后的血糖控制涉及神经内分泌变化和体重减轻.
- 胃底切除,主要的 ghrelin 生产部位,可能会影响葡萄糖调节.
- 研究改造的胃绕道用于增强糖尿病管理.
研究的目的:
- 评估腹腔镜Roux-en-Y胃绕道与底部切除 (LRYGBP+FR) 与标准LRYGBP相比改善了血糖控制.
- 评估 fundus切除对胃肠道激素水平和血糖参数的影响.
主要方法:
- 24名患有II型糖尿病的肥胖患者的随机试验.
- 在LRYGBP和LRYGBP+FR组之间进行比较.
- 在12个月内测量胃肠道激素 (格林,GLP-1,PYY) 和血糖标志物 (葡萄糖,胰岛素,HbA1c).
主要成果:
- 在两组中,12个月后95%的T2DM缓解.
- 与LRYGBP相比,LRYGBP+FR没有显示出优越的血糖控制.
- 在两组中,在食后观察到GLP-1和PYY的显著增加.
- 在12个月后,LRYGBP+FR导致BMI显著降低.
结论:
- 与标准LRYGBP相比,LRYGBP的 fundus切除并没有改善血糖调节.
- 通过LRYGBP+FR观察到的BMI降低需要进一步调查,并进行更长的随访.
相关概念视频
Diabetes: Management and Pharmacotherapy
302
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
302
Diabetes Mellitus: Type 2 and Gestational
2.5K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.5K
Chronic Pancreatitis II: Collaborative Care
108
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
108
Diabetes Mellitus: Overview and Type I Subtype
2.7K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.7K

